EUVIMEDEUVIMED entdecken
Open Access

Macrophage-Targeted Lipid Nanoparticle Delivery of microRNA-146a to Mitigate Hemorrhagic Shock-Induced Acute Respiratory Distress Syndrome

Qinqin Fei iD, Emily M Shalosky, Ryelie Barnes, Vasudha C Shukla, Siying Xu, Megan N Ballinger, Laszlo Farkas, Robert J Lee iD, Samir N Ghadiali, Joshua A Englert iD

ACS Nano · 12.09.2023 · 17 (17) · 16539-16552

DOI: 10.1021/acsnano.3c01814 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 18.08.2023. Verfasst von Qinqin Fei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, 500 West 12th Avenue, Columbus, Ohio 43210, United States. Hauptthemen laut MEDLINE: Lung Injury, Shock, Hemorrhagic, MicroRNAs, Respiratory Distress Syndrome. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pro-inflammatory response of alveolar macrophages to injurious physical forces during mechanical ventilation is regulated by the anti-inflammatory microRNA, miR-146a. Increasing miR-146a expression to supraphysiologic levels using untargeted lipid nanoparticles reduces ventilator-induced lung injury but requires a high initial dose of miR-146a making it less clinically applicable. In this study, we developed mannosylated lipid nanoparticles that can effectively mitigate lung injury at the initiation of mechanical ventilation with lower doses of miR-146a. We used a physiologically relevant humanized in vitro coculture system to evaluate the cell-specific targeting efficiency of the mannosylated lipid nanoparticle. We discovered that mannosylated lipid nanoparticles preferentially deliver miR-146a to alveolar macrophages and reduce force-induced inflammation in vitro. Our in vivo study using a clinically relevant mouse model of hemorrhagic shock-induced acute respiratory distress syndrome demonstrated that delivery of a low dose of miR-146a (0.1 nmol) using mannosylated lipid nanoparticles dramatically increases miR-146a levels in mouse alveolar macrophages and decreases lung inflammation. These data suggest that mannosylated lipid nanoparticles may have the therapeutic potential to mitigate lung injury during mechanical ventilation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung InjuryShock, HemorrhagicMicroRNAsRespiratory Distress SyndromeAnimalsMiceMacrophagesLiposomesNanoparticles

Stichwörter der Autor:innen

Mannosylated lipid nanoparticleacute respiratory distress syndromealveolar macrophagesinflammationmicroRNA

Substanzen

MicroRNAsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, 500 West 12th Avenue, Columbus, Ohio 43210, United States.
  • Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Columbus Ohio 43210, United States.
  • Department of Biomedical Engineering, The Ohio State University, 140 West 19th Avenue, Columbus, Ohio 43210, United States.
  • The Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, 473 West 12th Avenue, Columbus, Ohio 43210, United States.

ORCID-Profile: Qinqin Fei, Robert J Lee, Joshua A Englert

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute
  • U.S. Department of Defense
  • Eli Lilly and Company

Zitieren

APA

Fei, Q., Shalosky, E. M., Barnes, R., Shukla, V. C., Xu, S., Ballinger, M. N., Farkas, L., Lee, R. J., Ghadiali, S. N., & Englert, J. A. (2023). Macrophage-Targeted Lipid Nanoparticle Delivery of microRNA-146a to Mitigate Hemorrhagic Shock-Induced Acute Respiratory Distress Syndrome. ACS Nano, 17(17), 16539-16552. https://doi.org/10.1021/acsnano.3c01814

Vancouver

Fei Q, Shalosky EM, Barnes R, Shukla VC, Xu S, Ballinger MN, et al. Macrophage-Targeted Lipid Nanoparticle Delivery of microRNA-146a to Mitigate Hemorrhagic Shock-Induced Acute Respiratory Distress Syndrome. ACS Nano. 2023;17(17):16539-16552. doi:10.1021/acsnano.3c01814

BibTeX
@article{Fei2023,
  author = {Fei, Qinqin and Shalosky, Emily M and Barnes, Ryelie and Shukla, Vasudha C and Xu, Siying and Ballinger, Megan N and Farkas, Laszlo and Lee, Robert J and Ghadiali, Samir N and Englert, Joshua A},
  title = {Macrophage-Targeted Lipid Nanoparticle Delivery of microRNA-146a to Mitigate Hemorrhagic Shock-Induced Acute Respiratory Distress Syndrome},
  journal = {ACS Nano},
  year = {2023},
  volume = {17},
  number = {17},
  pages = {16539--16552},
  doi = {10.1021/acsnano.3c01814}
}
Kostenlos starten →